Press Releases
Introducing SMi’s6thannual conference on Pharmaceutical Freeze Drying Technologythis June 2018
SMi Group are delighted to announce the 6thannual Pharmaceutical Freeze Drying Technology conference, being held this June 2018! Read on for a massive £400 off. Optimising Pharmaceutical Technology Through Innovations & Novel Approaches In Freeze Drying...
Press Releases
Introducing SMi’s5th conference on Drug Safety 2018 this June
Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations of them, including the impact of the vital and much awaited Clinical Trial Regulations. ...
Press Releases
Discover Novel Based Vial Based Technology, Presented by Roche this May
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at Holiday Inn, Kensington Forum, London, on the 16th – 17th May...
Press Releases
Sarepta Therapeutics gazes FDA approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53
Sarepta Therapeutics, Inc , a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases. Announced that it recently received final minutes from a February 2018 Type C...
Press Releases
Largest Real-World Data Analysis Reveals Findings Of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants
Bristol-Myers Squibb Company and Pfizer Inc. will present findings from a real-world data (RWD) analysis titled, Comparison of Effectiveness, Safety, and the Net Clinical Outcome between Different Direct Oral Anticoagulants in 162,707 Non-Valvular Atrial Fibrillation Patients Treated in US...
Press Releases
Nanologicaand Sterling partnership furthers new business venture
Nanologica AB (publ) has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of silica particles. The partnership is the latest step in the development...
Press Releases
Latest technology for cell-based assays now also available for our entry-level product line
Cell-based assays have become an important application in the life science sector, from basic to top-level research. They are widely used in biotech companies and academic research institutions to monitor cell health in real-time. As experiments...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















